Will Lexicon Pharmaceuticals (LXRX) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 03/04/21
Biogen, 3D Systems, Duke Energy, Ford and More of Friday Afternoon's Analyst Calls24/7 Wall Street • 01/29/21
Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart FailureGlobeNewsWire • 01/14/21
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic NeuralgiaGlobeNewsWire • 12/31/20
Notable Insider Buys of the Past Week: Mylan, Sonabank, Steak 'n Shake, U-Haul And MoreBenzinga • 12/20/20
Lexicon Pharmaceuticals Receives Fast Track Designation From the FDA for LX9211 for Diabetic Peripheral Neuropathic PainGlobeNewsWire • 12/11/20